April 2017

• MonoSol Rx Appoints James S. Scibetta to Board of Directors

February 2017

• MonoSol RX Receives FDA Acceptance Of New Drug Application For Tadalafil PharmFilm®

January 2017

• John T. Maxwell Appointed CFO
• Patent Infringement Suit Against BDSI
• MonoSol Rx MonoSol Rx to Initiate Human Proof-of-Concept Study of Epinephrine Sublingual Soluble Film
• MonoSol Rx Successfully Completes Dose Proportionality Study of Diazepam Buccal Soluble Film to Treat Acute Repetitive Seizures
• MonoSol Rx Receives FDA Acceptance of Investigational New Drug Application for Riluzole Oral Soluble Film to Treat Amyotrophic Lateral Sclerosis

November 2016

• MONOSOL RX RECEIVES FDA ORPHAN DRUG DESIGNATION FOR DIAZEPAM BUCCAL SOLUBLE FILM TO TREAT ACUTE REPETITIVE SEIZURES
• MONOSOL RX SUBMITS NEW DRUG APPLICATION FOR TADALAFIL PHARMFILM®

September 2016

• MonoSol Rx Responds to Civil Complaint Filed by States Attorneys General

August 2016

• MonoSol Rx Closes $50 Million Credit Facility with Perceptive Advisors

June 2016

• MonoSol Rx wins patent infringement suit against Par Pharmaceutical and Watson Pharmaceuticals related to Suboxone® Sublingual Film

April 2016

• U.S. Patent and Trademark Office Upholds the Validity of MonoSol Rx’s US Patent No. 8,765,167 in the Face of Multiple Inter Partes Review Challenges Brought by BioDelivery Sciences International, Inc. (BDSI)
• Cynapsus Therapeutics and MonoSol Rx Announce Global IP Licensing Agreement

March 2016

• MonoSol Rx Successfully Completes Pre-IND Meeting with the FDA for PharmFilm® Tadalafil

January 2016

• MonoSol Rx Appoints Santo J. Costa to Board of Directors

December 2015

• MonoSol Rx Appoints Joanne M. Leonard as Chief Financial Officer

October 2015

• MonoSol Rx to Present at 2015 American Association of Pharmaceutical Scientists Annual Exposition Demonstrating PharmFilm as a Bioequivalent Delivery Platform for Sildenafil Citrate
• MonoSol Rx Leadership Presents Data Supporting PharmFilm Technology Effective for Oral Peptide Delivery

August 2015

• MonoSol Rx Partner Galena Biopharma Launches Zuplenz® (ondanestron) Oral Soluble Film

July 2015

• MonoSol Rx Announces Initiation of Phase 2a Trial for Oral Insulin Film

June 2015

• Galena Biopharma Launches Zuplenz® (ondansetron) Oral Soluble Film

March 2015

• Research Collaboration Signed with Global Pharmaceutical Company (via Midatech Pharma)

February 2015

• MonoSol Rx Leadership Presented PharmFilm Buccal Delivery Clinical Update at Leading Pharmaceutical Technology Meeting

December 2014

• MonoSol Rx names A. Mark Schobel Chief Innovation & Technology Officer; Keith Kendall assumes role of CEO

October 2014

• US Patent Office Institutes Inter Partes Review Brought by MonoSol Rx Against All Claims in Key BDSI BEMA Patent

August 2014

• MonoSol Rx Launches Clinical Study of MSRX-110 Oral Film for Testosterone Replacement

December 2012

• MonoSol Rx Acquires U.S. Patent for Multifunctional Single Layer Film Drug Delivery Technology

October 2012

• MonoSol Rx Defeats BDSI’s Reexamination Challenges to MonoSol Rx’s PharmFilm® Patents

September 2012

• MonoSol Rx Developing Migraine Product for Treatment of Pain and Nausea in a Single Dose

May 2012

• Midatech and MonoSol Rx Announce Positive Phase 1 Clinical Results for their Novel Transbuccal Oral Insulin Film Product

February 2012

• Monosol Rx, LLC Remains Confident in its Patent Portfolio

January 2012

• MonoSol Rx and Midatech Launch MidaSol Therapeutics LP

November 2011

• MonoSol Rx Announces Listing of Patent in FDA Orange Book for Suboxone® Sublingual Films
• MonoSol Rx, LLC Remains Confident in its Patent Portfolio
• MonoSol Rx and Midatech Ltd Receive Authorization to Conduct Phase I Human Trials for Transbuccal Insulin PharmFilm®

October 2011

• MonoSol Rx, LLC Asserts Additional Patents to Infringement Lawsuit Against BioDelivery Sciences International, Inc.
• MonoSol Rx Strengthens Canadian Patent Portfolio for PharmFilm®

August 2011

• MonoSol Rx Announces Second PharmFilm® Product for ADHD

June 2011

• MonoSol Rx Aligns Executive Leadership to Maximize Growth Opportunities, Operational Excellence and R&D Pipeline

April 2011

• MonoSol Rx and KemPharm to Develop Novel PharmFilm® Product for ADHD

September 2010

• Warren- based MonoSol Rx Introduces New Methods of Admnistering Medicine

August 2010

• MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone Sublingual Film for Treatment of Opioid Dependence
• Midatech and MonoSol Rx Announce Filing of Joint Patent Application for Nanoparticle File Delivery Systems

July 2010

• MonoSol Rx Announces FDA Approval of ZuplenzB. Oral Soluble Film for Treatment of Nausea and Vomiting

June 2010

• MonoSol Rx Expands Collarboration with Midatech to Deliver Peptides Utilizing its PharmFilmB. Drug Delivery Technology
• MonoSol Rx Appoints Dr. Eric Dadey Senior Vice President, Pharmaceutical Development
• MonoSol Rx Appoints Dr. Mary Ellen Norvitch Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance

July 2009

• MonoSol Rx Appoints Theodore Clemente Vice President Business Development

June 2009

• MonoSol Rx Announces FDA Acceptance of NDA for Ondansetron Orally Dissolving Film Strip

April 2009

• MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip
• MonoSol Rx Granted U.S. Article of Manufacture Patent

March 2009

• MonoSol Rx to Present at Cowen & Company 29th Annual Health Care Conference
• MonoSol Rx Achieves Milestones for Additional $2.5 Million Private Debt Financing

December 2008

• MonoSol Rx Enters Agreement with Hikma Pharmaceuticals PLC for Thin Film Pharmaceutical Products in the Middle East
• MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA

November 2008

• MonoSol Rx to Present at the 20th Annual Piper Jaffray Health Care Conference
• MonoSol Rx and Midatech Group Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies

September 2008

• MonoSol Rx Closes $20 Million in Private Equity Financing
• MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process

August 2008

• MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Bioequivalence Study

June 2008

• MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical
• MonoSol Rx Closes $10 Million in Private Debt Financing
• MonoSol Rx Names Vincent Viviani Senior Vice President, Manufacturing and Operations

May 2008

• MonoSol Rx Appoints John McCracken Senior Vice President Business Development

April 2008

• MonoSol Rx, LLC granted US patent for thin film manufacturing process

February 2008

• MonoSol Rx, LLC completes thin film ondansetron pilot bioequivalence study

April 2007

• MonoSol Rx Announces Hiring of Larry W. Kranking as Senior Vice-President, Pharmaceutical Operations

December 2006

• MonoSolRx Closes $38 Million Preferred Equity Investment

September 2006

• MonoSolRx to Present at the UBS Global Life Sciences Conference

July 2006

• MonoSolRx Announces Hiring of Keith Kendall as Chief Financial Officer
• MonoSol Rx Completes Successful DEA Registration of Both Its Manufacturing Facility and Development Facility

June 2006

• MonoSol Rx Completes Analytical Laboratories to Support Film Based Drug Development and Manufacturing

May 2006

• MonoSol Rx Announces Legal Settlement With Novartis Consumer Health Relating